Endothelial nitric oxide synthase polymorphisms do not influence pulmonary artery systolic pressure at altitude

High Altitude Medicine and Biology

Volumn 7, Issue 3, 2006, Pages 221-227

  Smith, Eve M D ^a   Baillie, J Kenneth ^b   Thompson, A A Roger ^b   Irving, John B ^b   Porteous, David ^c   Webb, David J ^d  

^a WESTERN INFIRMARY   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Caucasian; Echocardiography; Genetics; High altitude pulmonary edema; Hypoxic pulmonary vasoconstriction

Indexed keywords

ASPARTIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMIC ACID;

ADULT; ALTITUDE; ARTICLE; BASE PAIRING; BLOOD PRESSURE MEASUREMENT; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; HUMAN; HUMAN EXPERIMENT; LUNG ARTERY PRESSURE; LUNG EDEMA; LUNG HEMODYNAMICS; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY; VARIABLE NUMBER OF TANDEM REPEAT; VOLUNTEER;

ADOLESCENT; ADULT; ALTITUDE; ALTITUDE SICKNESS; BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; PULMONARY ARTERY; PULMONARY EDEMA;

EID: 33846524379     PISSN: 15270297     EISSN: None     Source Type: Journal    
DOI: 10.1089/ham.2006.7.221     Document Type: Article

References (26)

1. Allemann Y., Sartori C., Lepori M., Pierre S., Melot C., Scherrer U., and Maggiorini M. (2000). Echocardiographic and invasive measurements of pulmonary artery pressure correlate closely at high altitude. Am. J. Physiol. Heart. Circ. Physiol. 279:H2013-H2016.
2. Anand I.S., Prasad B.A.K., Chugh S.S., Rao K.R., Cornfield D.N., Milla C.E., Singh N., Singh S., and Selvamurthy W. (1998). Effect of inhaled nitric oxide and oxygen in high altitude pulmonary edema. Circulation. 98:2441-2445.
3. Bartsch P., Maggiorini M., Ritter M., Noti C., Vock P., and Oelz O. (1991). Prevention of high-altitude pulmonary edema by nifedipine. N. Engl. J. Med. 325: 1284-1289.
4. Bartsch P., Swenson E.R., and Maggiorini M. (2001). Update: high altitude pulmonary oedema. Adv. Exp. Med. Biol. 502:89-107.
5. Benjafield B.V., and Morris B.J. (2000). Association analyses of endothelial nitric oxide synthase gene polymorphisms in essential hypertension. Am. J. Hypertens. 13:994-998.
6. Blitzer M.L., Lone R., Roddy M.A., Stamler J.S., and Creager M.A. (1996). Endothelium derived nitric oxide regulates pulmonary and systemic vascular resistance during acute hypoxia in humans. J. Am. Coll. Cardiol. 28:591-596.
7. Busch T., Bartsch P., Pappert D., Grunig E., Hildebrandt W., Elser H., Falke K.J., and Swenson E.R. (2001). Hypoxia decreases exhaled nitric oxide in mountaineers susceptible to high-altitude pulmonary edema. Am. J. Respir. Crit. Care Med. 163:368-373.
8. Dehnert C., Weymann J., Montgomery H.E., Woods D., Maggiorini M., Scherrer U., Gibbs J.S., and Bartsch P. (2002). No association between high-altitude tolerance and the ACE I/D gene polymorphism. Med. Sci. Sports Exerc. 34:1928-1933.
9. Droma Y., Hanaoka M., Ota M., Katsuyama Y., Koizumi T., Fujimoto K., Kobayashi T., and Kubo K. (2002). Positive association of the endothelial nitric oxide synthase gene polymorphisms with high-altitude pulmonary edema. Circulation. 106:826-830.
10. Duplain H., Sartori C., Lepori M., Egli M., Allemann Y., Nicod P., and Scherrer U. (2000). Exhaled nitric oxide in high-altitude pulmonary edema. Role in the regulation of pulmonary vascular tone and evidence for a role against inflammation. Am. J. Respir. Crit. Care Med. 162:221-224.
11. Fagan K.A.. Fouty B.W., Tyler R.C., Morris K.G., Jr., Hepler L.K., Sato K., LeCras T.D., Abman S.H., Weinberger H.D., Huang P.L., McMurtry I.F., and Rodman D.M. (1999). The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. J. Clin. Invest. 103:291-299.
12. Hampl V., and Herget J. (2000). Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension. Physiol. Rev. 80:1337-1361.
13. 298 -→ Asp) is a major risk factor for coronary artery disease in the UK. Circulation. 100:1515-1520.
14. Hotta J., Hanaoka M., Droma Y., Katsuyama Y., Ota M., and Kobayashi T. (2004). Polymorphisms of renin-angiotensin system genes with high-altitude pulmonary edema in Japanese subjects. Chest. 126:825-830.
15. Kumar R., Pasha Q., Khan A.P., and Gupta V. (2004). Renin angiotensin aldosterone system and ACE I/D gene polymorphism in high-altitude pulmonary edema. Aviat. Space Environ. Med. 75:981-983.
16. Livak K.J., Marmaro J., and Todd J.A. (1995). Towards fully automated genome-wide polymorphism screening. Nat. Genet. 9:341-342.
17. MacLeod M.J., Dahiyat M.T., Cumming A., Meiklejohn D., Shaw D., and St Clair D. (1999). No association between Glu/Asp polymorphism of NOS3 gene and ischemic stroke. Neurology. 53:418-425.
18. Maggiorini M., Melot C., Pierre S., Pfeiffer F., Greve I., Sartori C., Lepori M., Hauser M., Scherrer U., and Naeije R. (2001). High-altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation. 103:2078-2083.
19. Marsden P.A., Heng H.H.Q., Scherer S.W., Stewart R.J., Hall A.V., Shi X.M., Tsui L.C., and Schappert K.T. (1993). Structure and chromosomal localisation of the human constitutive endothelial nitric oxide synthase gene. J. Biol. Chem. 268:17478-17488.
20. Montgomery H.E., Marshall R., Hemingway H., Myerson S., Clarkson P., Dollery C., Hayward M., Holliman D.E., Jubb M., World M., Thomas E.L., Brynes A.E., Saeed N., Barnard M., Bell J.D., Prasad K., Rayson M., Talmud P.J., and Humphries S.E. (1998). Human gene for physical performance. Nature. 393:221-222.
21. Mortimer H., Patel S., and Peacock A.J. (2004). The genetic basis of high-altitude pulmonary oedema. Pharmacol. Ther. 101:183-192.
22. Oelz O., Maggiorini M., Ritter M., Waber U., Jenni R., Vock P., and Bartsch P. (1989). Nifedipine for high altitude pulmonary oedema. Lancet. 2:1241-1244.
23. Scherrer U., Vollenweider L., Delabays A., Savcic M., Eichenberger U., Kleger G.R., Fikrle A., Ballmer P.E., Nicod P., and Bartsch P. (1996). Inhaled nitric oxide for high altitude pulmonary edema. N. Engl. J. Med. 334:624-629.
24. Shoji M., Tsutaya S., Saito R., Takamatu H., and Yasujima M. (2000). Positive association of endothelial nitric oxide synthase gene polymorphisms with hypertension in northern Japan. Life Sci. 66:2557-2562.
25. Steudel W., Ichinose F., Huang P.L., Hurford W.E., Jones R.C., Bevan J.A., Fishman M.C., and Zapol W.M. (1997). Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase gene. Circ. Res. 81:34-41.
26. Weiss J., Haefeli W.E., Gasse C., Hoffmann M.M., Weyman J., Gibbs S., Mansmann U., and Bartsch P. (2003). Lack of evidence for association of high altitude pulmonary edema and polymorphisms of the NO pathway. High Alt. Med. Biol. 4:355-366.